Diagnostic performance of two non-invasive biomarkers used individually and in sequential combination for cirrhosis associated with hepatitis C virus infection
Abstract This cross-sectional study evaluated the performance of the Aspartate Aminotransferase-to-Platelet Ratio Index (APRI) and the Fibrosis-4 (FIB-4) Index when they were used individually and in sequential combination to diagnose cirrhosis associated with hepatitis C virus infection. The final...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-11-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-24612-9 |
_version_ | 1797986893384646656 |
---|---|
author | Mohd Azri Mohd Suan Huan Keat Chan Xiaohui Sem Sonjelle Shilton Muhammad Radzi Abu Hassan |
author_facet | Mohd Azri Mohd Suan Huan Keat Chan Xiaohui Sem Sonjelle Shilton Muhammad Radzi Abu Hassan |
author_sort | Mohd Azri Mohd Suan |
collection | DOAJ |
description | Abstract This cross-sectional study evaluated the performance of the Aspartate Aminotransferase-to-Platelet Ratio Index (APRI) and the Fibrosis-4 (FIB-4) Index when they were used individually and in sequential combination to diagnose cirrhosis associated with hepatitis C virus infection. The final evaluation involved 906 people living with hepatitis C. The diagnostic performance of individual biomarkers at cut-off scores of 1.5 and 2.0 for the APRI and at 3.25 for the FIB-4 index was assessed. For the sequential combination method, the cirrhosis status of individuals with an APRI score between 1.0 and 1.5 were reassessed using the FIB-4. Transient elastography (TE) was used as the reference standard for diagnosing cirrhosis. The APRI, at a cut-off score of 1.5, showed a sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of 44.9%, 97.6%, 91.1% and 76.3%, respectively. Increasing the cut-off score to 2.0 produced a much lower sensitivity (29.6%) and NPV (71.9%). The FIB-4, at a cut-off score of 3.25, yielded a sensitivity, specificity, PPV and NPV of 40.8%, 97.3%, 89.1% and 75.0%, respectively. The sequential combination method demonstrated a much more optimal diagnostic performance (50.2% sensitivity, 96.6% specificity, 89.0% PPV and 77.9% NPV). Overall, the APRI and FIB-4 Index performed better in diagnosing cirrhosis associated with hepatitis C when they were used in sequential combination. |
first_indexed | 2024-04-11T07:39:08Z |
format | Article |
id | doaj.art-fdcef962a391413e9a08ca097f45bb42 |
institution | Directory Open Access Journal |
issn | 2045-2322 |
language | English |
last_indexed | 2024-04-11T07:39:08Z |
publishDate | 2022-11-01 |
publisher | Nature Portfolio |
record_format | Article |
series | Scientific Reports |
spelling | doaj.art-fdcef962a391413e9a08ca097f45bb422022-12-22T04:36:38ZengNature PortfolioScientific Reports2045-23222022-11-011211810.1038/s41598-022-24612-9Diagnostic performance of two non-invasive biomarkers used individually and in sequential combination for cirrhosis associated with hepatitis C virus infectionMohd Azri Mohd Suan0Huan Keat Chan1Xiaohui Sem2Sonjelle Shilton3Muhammad Radzi Abu Hassan4Clinical Research Centre, Hospital Sultanah Bahiyah, Ministry of HealthClinical Research Centre, Hospital Sultanah Bahiyah, Ministry of HealthFINDFINDOffice of Deputy Director General, Ministry of Health MalaysiaAbstract This cross-sectional study evaluated the performance of the Aspartate Aminotransferase-to-Platelet Ratio Index (APRI) and the Fibrosis-4 (FIB-4) Index when they were used individually and in sequential combination to diagnose cirrhosis associated with hepatitis C virus infection. The final evaluation involved 906 people living with hepatitis C. The diagnostic performance of individual biomarkers at cut-off scores of 1.5 and 2.0 for the APRI and at 3.25 for the FIB-4 index was assessed. For the sequential combination method, the cirrhosis status of individuals with an APRI score between 1.0 and 1.5 were reassessed using the FIB-4. Transient elastography (TE) was used as the reference standard for diagnosing cirrhosis. The APRI, at a cut-off score of 1.5, showed a sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of 44.9%, 97.6%, 91.1% and 76.3%, respectively. Increasing the cut-off score to 2.0 produced a much lower sensitivity (29.6%) and NPV (71.9%). The FIB-4, at a cut-off score of 3.25, yielded a sensitivity, specificity, PPV and NPV of 40.8%, 97.3%, 89.1% and 75.0%, respectively. The sequential combination method demonstrated a much more optimal diagnostic performance (50.2% sensitivity, 96.6% specificity, 89.0% PPV and 77.9% NPV). Overall, the APRI and FIB-4 Index performed better in diagnosing cirrhosis associated with hepatitis C when they were used in sequential combination.https://doi.org/10.1038/s41598-022-24612-9 |
spellingShingle | Mohd Azri Mohd Suan Huan Keat Chan Xiaohui Sem Sonjelle Shilton Muhammad Radzi Abu Hassan Diagnostic performance of two non-invasive biomarkers used individually and in sequential combination for cirrhosis associated with hepatitis C virus infection Scientific Reports |
title | Diagnostic performance of two non-invasive biomarkers used individually and in sequential combination for cirrhosis associated with hepatitis C virus infection |
title_full | Diagnostic performance of two non-invasive biomarkers used individually and in sequential combination for cirrhosis associated with hepatitis C virus infection |
title_fullStr | Diagnostic performance of two non-invasive biomarkers used individually and in sequential combination for cirrhosis associated with hepatitis C virus infection |
title_full_unstemmed | Diagnostic performance of two non-invasive biomarkers used individually and in sequential combination for cirrhosis associated with hepatitis C virus infection |
title_short | Diagnostic performance of two non-invasive biomarkers used individually and in sequential combination for cirrhosis associated with hepatitis C virus infection |
title_sort | diagnostic performance of two non invasive biomarkers used individually and in sequential combination for cirrhosis associated with hepatitis c virus infection |
url | https://doi.org/10.1038/s41598-022-24612-9 |
work_keys_str_mv | AT mohdazrimohdsuan diagnosticperformanceoftwononinvasivebiomarkersusedindividuallyandinsequentialcombinationforcirrhosisassociatedwithhepatitiscvirusinfection AT huankeatchan diagnosticperformanceoftwononinvasivebiomarkersusedindividuallyandinsequentialcombinationforcirrhosisassociatedwithhepatitiscvirusinfection AT xiaohuisem diagnosticperformanceoftwononinvasivebiomarkersusedindividuallyandinsequentialcombinationforcirrhosisassociatedwithhepatitiscvirusinfection AT sonjelleshilton diagnosticperformanceoftwononinvasivebiomarkersusedindividuallyandinsequentialcombinationforcirrhosisassociatedwithhepatitiscvirusinfection AT muhammadradziabuhassan diagnosticperformanceoftwononinvasivebiomarkersusedindividuallyandinsequentialcombinationforcirrhosisassociatedwithhepatitiscvirusinfection |